The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 125:1640-1646, June 1969
doi: 10.1176/appi.ajp.125.12.1640
© 1969 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by KAIM, S. C.
* Articles by ROTHFELD, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by KAIM, S. C.
* Articles by ROTHFELD, B.

Treatment of the Acute Alcohol Withdrawal State: A Comparison of Four Drugs

S. C. KAIM M.D.1, C. J. KLETT PH.D.2, , and BENJAMIN ROTHFELD M.D.3

1 Director, staff for alcoholism and related disorders, Veterans Administration Central Office. Washington, D. C. 20420
2 Chief, Central Neuropsychiatric Research Laboratory, Veterans Administration Hospital, Perry Point, Md.
3 Associate chief of staff, Veterans Administration Hospital, Perry Point, Md.

A double-blind study of 537 patients evaluated the relative efficacy of four drugs—chlordiazepoxide, chlorpromazine, hydroxyzine, and thiamine—commonly used in treating alcohol withdrawal symptoms, specifically to prevent delirium tremens and convulsions. Of the 55 patients who developed these symptoms, two percent were in the chlordiazepoxide group; the incidence ranged from ten to 16 percent in the other treatment groups. The authors conclude that chlordiazepoxide appears to be the drug of choice among those tested.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
J.-B. Daeppen, P. Gache, U. Landry, E. Sekera, V. Schweizer, S. Gloor, and B. Yersin
Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal: A Randomized Treatment Trial
Arch Intern Med, May 27, 2002; 162(10): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. D'Onofrio, N. K. Rathlev, A. S. Ulrich, S. S. Fish, and E. S. Freedland
Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol
N. Engl. J. Med., March 25, 1999; 340(12): 915 - 919.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. J. Klett, P. Point, L. E. Hollister, P. Alto, E. M. Caffey Jr., and S. C. Kaim
Evaluating Changes in Symptoms During Acute Alcohol Withdrawal
Arch Gen Psychiatry, February 1, 1971; 24(2): 174 - 178.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1969 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org